CONTEXT: Inverse associations are reported between circulating 25-hydroxyvitamin D and visceral adiposity. The effects of vitamin D levels on atherosclerosis are unknown. OBJECTIVE: The objective of this study was to test for relationships between vitamin D, adiposity, bone density, and atherosclerosis in African-Americans. DESIGN: Circulating 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, intact PTH, C-reactive protein and computed tomography-derived calcified atherosclerotic plaque (CP), bone density, and fat volumes were measured. SETTING: Examinations were performed at a single outpatient general clinical research center visit. SUBJECTS: Three hundred forty African-Americans with type 2 diabetes were evaluated. Mean +/- SD age was 55.6 +/- 9.6 yr, diabetes duration 10.6 +/- 8.3 yr, glomerular filtration rate 1.6 +/- 0.5 ml/sec, body mass index 35.6 +/- 8.7 kg/m(2), and 25-hydroxyvitamin D concentration 50.4 +/- 30.5 nmol/liter. MAIN OUTCOME MEASURE: Biomarkers were tested for association with pericardial, visceral, im, and sc adipose tissues; thoracic and lumbar vertebral bone density; and aorta, coronary, and carotid artery CP. RESULTS: Adjusting for age, gender, body mass index, glycosylated hemoglobin, and glomerular filtration rate, 25-hydroxyvitamin D was negatively associated with visceral adiposity (P = 0.009) and positively associated with carotid artery CP and aorta CP (P = 0.013 and 0.014, respectively) but not with coronary artery CP or bone density. CONCLUSIONS: We confirmed an inverse association between vitamin D and visceral adiposity in African-Americans with diabetes. In addition, positive associations exist between 25-hydroxyvitamin D and aorta and carotid artery CP in African-Americans. The effects of supplementing vitamin D to raise the serum 25-hydroxyvitamin D level on atherosclerosis in African-Americans are unknown. Prospective trials are needed to determine the cardiovascular effects of supplemental vitamin D in this ethnic group.
CONTEXT: Inverse associations are reported between circulating 25-hydroxyvitamin D and visceral adiposity. The effects of vitamin D levels on atherosclerosis are unknown. OBJECTIVE: The objective of this study was to test for relationships between vitamin D, adiposity, bone density, and atherosclerosis in African-Americans. DESIGN: Circulating 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, intact PTH, C-reactive protein and computed tomography-derived calcified atherosclerotic plaque (CP), bone density, and fat volumes were measured. SETTING: Examinations were performed at a single outpatient general clinical research center visit. SUBJECTS: Three hundred forty African-Americans with type 2 diabetes were evaluated. Mean +/- SD age was 55.6 +/- 9.6 yr, diabetes duration 10.6 +/- 8.3 yr, glomerular filtration rate 1.6 +/- 0.5 ml/sec, body mass index 35.6 +/- 8.7 kg/m(2), and 25-hydroxyvitamin D concentration 50.4 +/- 30.5 nmol/liter. MAIN OUTCOME MEASURE: Biomarkers were tested for association with pericardial, visceral, im, and sc adipose tissues; thoracic and lumbar vertebral bone density; and aorta, coronary, and carotid artery CP. RESULTS: Adjusting for age, gender, body mass index, glycosylated hemoglobin, and glomerular filtration rate, 25-hydroxyvitamin D was negatively associated with visceral adiposity (P = 0.009) and positively associated with carotid artery CP and aorta CP (P = 0.013 and 0.014, respectively) but not with coronary artery CP or bone density. CONCLUSIONS: We confirmed an inverse association between vitamin D and visceral adiposity in African-Americans with diabetes. In addition, positive associations exist between 25-hydroxyvitamin D and aorta and carotid artery CP in African-Americans. The effects of supplementing vitamin D to raise the serum 25-hydroxyvitamin D level on atherosclerosis in African-Americans are unknown. Prospective trials are needed to determine the cardiovascular effects of supplemental vitamin D in this ethnic group.
Authors: Mercedes R Carnethon; Alain G Bertoni; Steven Shea; Philip Greenland; Hanyu Ni; David R Jacobs; Mohammed Saad; Kiang Liu Journal: Diabetes Care Date: 2005-11 Impact factor: 19.112
Authors: Guy L Wheeler; Rong Shi; Stephanie R Beck; Carl D Langefeld; Leon Lenchik; Lynne E Wagenknecht; Barry I Freedman; Stephen S Rich; Donald W Bowden; Michael Y Chen; J Jeffrey Carr Journal: Invest Radiol Date: 2005-02 Impact factor: 6.016
Authors: John P Forman; Heike A Bischoff-Ferrari; Walter C Willett; Meir J Stampfer; Gary C Curhan Journal: Hypertension Date: 2005-09-06 Impact factor: 10.190
Authors: Diane E Bild; Robert Detrano; Do Peterson; Alan Guerci; Kiang Liu; Eyal Shahar; Pamela Ouyang; Sharon Jackson; Mohammed F Saad Journal: Circulation Date: 2005-03-15 Impact factor: 29.690
Authors: Robert C Detrano; Melissa Anderson; Jennifer Nelson; Nathan D Wong; J Jeffrey Carr; Michael McNitt-Gray; Diane E Bild Journal: Radiology Date: 2005-06-21 Impact factor: 11.105
Authors: B I Freedman; F C Hsu; C D Langefeld; S S Rich; D M Herrington; J J Carr; J Xu; D W Bowden; L E Wagenknecht Journal: Diabetologia Date: 2005-11-01 Impact factor: 10.122
Authors: László B Tankó; Claus Christiansen; David A Cox; Mary Jane Geiger; Michelle A McNabb; Steven R Cummings Journal: J Bone Miner Res Date: 2005-07-18 Impact factor: 6.741
Authors: Rebecca D Jackson; Andrea Z LaCroix; Margery Gass; Robert B Wallace; John Robbins; Cora E Lewis; Tamsen Bassford; Shirley A A Beresford; Henry R Black; Patricia Blanchette; Denise E Bonds; Robert L Brunner; Robert G Brzyski; Bette Caan; Jane A Cauley; Rowan T Chlebowski; Steven R Cummings; Iris Granek; Jennifer Hays; Gerardo Heiss; Susan L Hendrix; Barbara V Howard; Judith Hsia; F Allan Hubbell; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis H Kuller; Robert D Langer; Norman L Lasser; Marian C Limacher; Shari Ludlam; JoAnn E Manson; Karen L Margolis; Joan McGowan; Judith K Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Gloria E Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Evelyn Whitlock; Garnet L Anderson; Annlouise R Assaf; David Barad Journal: N Engl J Med Date: 2006-02-16 Impact factor: 91.245
Authors: Jigar Chotalia; Maria Frontini; Priyanka Tatini; M Jacques Nsuami; David H Martin; Rebecca A Clark Journal: J Acquir Immune Defic Syndr Date: 2012-04-01 Impact factor: 3.731
Authors: Michelle Y O'Connor; Caroline K Thoreson; Natalie L M Ramsey; Madia Ricks; Anne E Sumner Journal: Prog Cardiovasc Dis Date: 2013 Nov-Dec Impact factor: 8.194
Authors: Thomas C Register; Keith A Hruska; Jasmin Divers; Donald W Bowden; Nicholette D Palmer; J Jeffrey Carr; Lynne E Wagenknecht; R Caresse Hightower; Jianzhao Xu; S Carrie Smith; Dennis J Dietzen; Carl D Langefeld; Barry I Freedman Journal: J Clin Endocrinol Metab Date: 2013-12-20 Impact factor: 5.958
Authors: Martine F Luxwolda; Remko S Kuipers; Ido P Kema; E van der Veer; D A Janneke Dijck-Brouwer; Frits A J Muskiet Journal: Eur J Nutr Date: 2012-08-10 Impact factor: 5.614
Authors: Hong Lai; Gary Gerstenblith; Elliot K Fishman; Jeffrey Brinker; Thomas Kickler; Wenjing Tong; Sundeepan Bhatia; Tai Hong; Shaoguang Chen; Ji Li; Barbara Detrick; Shenghan Lai Journal: Clin Infect Dis Date: 2012-03-15 Impact factor: 9.079
Authors: Patricia A O Soares; Cristiane Kovacs; Priscila Moreira; Mohamed H Saleh; Daniel Magnoni; Joel Faintuch Journal: Obes Surg Date: 2012-03 Impact factor: 4.129